136 related articles for article (PubMed ID: 28057482)
1. Distinguishing between expert and statistical systems for application under ICH M7.
Barber C; Hanser T; Judson P; Williams R
Regul Toxicol Pharmacol; 2017 Mar; 84():124-130. PubMed ID: 28057482
[No Abstract] [Full Text] [Related]
2. Carbamates and ICH M7 classification: Making use of expert knowledge.
Hemingway R; Fowkes A; Williams RV
Regul Toxicol Pharmacol; 2017 Jun; 86():392-401. PubMed ID: 28385577
[TBL] [Abstract][Full Text] [Related]
3. Establishing best practise in the application of expert review of mutagenicity under ICH M7.
Barber C; Amberg A; Custer L; Dobo KL; Glowienke S; Van Gompel J; Gutsell S; Harvey J; Honma M; Kenyon MO; Kruhlak N; Muster W; Stavitskaya L; Teasdale A; Vessey J; Wichard J
Regul Toxicol Pharmacol; 2015 Oct; 73(1):367-77. PubMed ID: 26248005
[TBL] [Abstract][Full Text] [Related]
4. Principles and procedures for implementation of ICH M7 recommended (Q)SAR analyses.
Amberg A; Beilke L; Bercu J; Bower D; Brigo A; Cross KP; Custer L; Dobo K; Dowdy E; Ford KA; Glowienke S; Van Gompel J; Harvey J; Hasselgren C; Honma M; Jolly R; Kemper R; Kenyon M; Kruhlak N; Leavitt P; Miller S; Muster W; Nicolette J; Plaper A; Powley M; Quigley DP; Reddy MV; Spirkl HP; Stavitskaya L; Teasdale A; Weiner S; Welch DS; White A; Wichard J; Myatt GJ
Regul Toxicol Pharmacol; 2016 Jun; 77():13-24. PubMed ID: 26877192
[TBL] [Abstract][Full Text] [Related]
5. (Q)SAR assessments of potentially mutagenic impurities: a regulatory perspective on the utility of expert knowledge and data submission.
Powley MW
Regul Toxicol Pharmacol; 2015 Mar; 71(2):295-300. PubMed ID: 25545315
[TBL] [Abstract][Full Text] [Related]
6. Transitioning to composite bacterial mutagenicity models in ICH M7 (Q)SAR analyses.
Landry C; Kim MT; Kruhlak NL; Cross KP; Saiakhov R; Chakravarti S; Stavitskaya L
Regul Toxicol Pharmacol; 2019 Dec; 109():104488. PubMed ID: 31586682
[TBL] [Abstract][Full Text] [Related]
7. A consortium-driven framework to guide the implementation of ICH M7 Option 4 control strategies.
Barber C; Antonucci V; Baumann JC; Brown R; Covey-Crump E; Elder D; Elliott E; Fennell JW; Gallou F; Ide ND; Jordine G; Kallemeyn JM; Lauwers D; Looker AR; Lovelle LE; McLaughlin M; Molzahn R; Ott M; Schils D; Oestrich RS; Stevenson N; Talavera P; Teasdale A; Urquhart MW; Varie DL; Welch D
Regul Toxicol Pharmacol; 2017 Nov; 90():22-28. PubMed ID: 28822875
[TBL] [Abstract][Full Text] [Related]
8. Use of in silico systems and expert knowledge for structure-based assessment of potentially mutagenic impurities.
Sutter A; Amberg A; Boyer S; Brigo A; Contrera JF; Custer LL; Dobo KL; Gervais V; Glowienke S; van Gompel J; Greene N; Muster W; Nicolette J; Reddy MV; Thybaud V; Vock E; White AT; Müller L
Regul Toxicol Pharmacol; 2013 Oct; 67(1):39-52. PubMed ID: 23669331
[TBL] [Abstract][Full Text] [Related]
9. Extending (Q)SARs to incorporate proprietary knowledge for regulatory purposes: A case study using aromatic amine mutagenicity.
Ahlberg E; Amberg A; Beilke LD; Bower D; Cross KP; Custer L; Ford KA; Van Gompel J; Harvey J; Honma M; Jolly R; Joossens E; Kemper RA; Kenyon M; Kruhlak N; Kuhnke L; Leavitt P; Naven R; Neilan C; Quigley DP; Shuey D; Spirkl HP; Stavitskaya L; Teasdale A; White A; Wichard J; Zwickl C; Myatt GJ
Regul Toxicol Pharmacol; 2016 Jun; 77():1-12. PubMed ID: 26879463
[TBL] [Abstract][Full Text] [Related]
10. Assessing the impact of expert knowledge on ICH M7 (Q)SAR predictions. Is expert review still needed?
Jayasekara PS; Skanchy SK; Kim MT; Kumaran G; Mugabe BE; Woodard LE; Yang J; Zych AJ; Kruhlak NL
Regul Toxicol Pharmacol; 2021 Oct; 125():105006. PubMed ID: 34273441
[TBL] [Abstract][Full Text] [Related]
11. A novel QSAR model of Salmonella mutagenicity and its application in the safety assessment of drug impurities.
Valencia A; Prous J; Mora O; Sadrieh N; Valerio LG
Toxicol Appl Pharmacol; 2013 Dec; 273(3):427-34. PubMed ID: 24090816
[TBL] [Abstract][Full Text] [Related]
12. Mutagenicity assessment strategy for pharmaceutical intermediates to aid limit setting for occupational exposure.
Araya S; Lovsin-Barle E; Glowienke S
Regul Toxicol Pharmacol; 2015 Nov; 73(2):515-20. PubMed ID: 26454093
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a statistics-based Ames mutagenicity QSAR model and interpretation of the results obtained.
Barber C; Cayley A; Hanser T; Harding A; Heghes C; Vessey JD; Werner S; Weiner SK; Wichard J; Giddings A; Glowienke S; Parenty A; Brigo A; Spirkl HP; Amberg A; Kemper R; Greene N
Regul Toxicol Pharmacol; 2016 Apr; 76():7-20. PubMed ID: 26708083
[TBL] [Abstract][Full Text] [Related]
14. Proximity to the US-Mexico border: a key to explaining geographic variation in US methamphetamine, cocaine and heroin purity.
Cunningham JK; Maxwell JC; Campollo O; Cunningham KI; Liu LM; Lin HL
Addiction; 2010 Oct; 105(10):1785-98. PubMed ID: 20682010
[TBL] [Abstract][Full Text] [Related]
15. An evaluation of in-house and off-the-shelf in silico models: implications on guidance for mutagenicity assessment.
Jolly R; Ahmed KB; Zwickl C; Watson I; Gombar V
Regul Toxicol Pharmacol; 2015 Apr; 71(3):388-97. PubMed ID: 25656493
[TBL] [Abstract][Full Text] [Related]
16. Development of the risk-based, phased-in approach for the international harmonization of the regulation of container closure systems for drugs in Taiwan.
Chang LC; Kang JJ; Gau CS
Regul Toxicol Pharmacol; 2016 Jun; 77():252-6. PubMed ID: 27016398
[TBL] [Abstract][Full Text] [Related]
17. The application of structure-activity relationships to the prediction of the mutagenic activity of chemicals.
Judson P
Methods Mol Biol; 2012; 817():1-19. PubMed ID: 22147565
[TBL] [Abstract][Full Text] [Related]
18.
Benigni R; Bassan A; Pavan M
Expert Opin Drug Metab Toxicol; 2020 Aug; 16(8):651-662. PubMed ID: 32567390
[TBL] [Abstract][Full Text] [Related]
19. Validation of Toxtree and SciQSAR in silico predictive software using a publicly available benchmark mutagenicity database and their applicability for the qualification of impurities in pharmaceuticals.
Contrera JF
Regul Toxicol Pharmacol; 2013 Nov; 67(2):285-93. PubMed ID: 23969001
[TBL] [Abstract][Full Text] [Related]
20. A practical application of two in silico systems for identification of potentially mutagenic impurities.
Greene N; Dobo KL; Kenyon MO; Cheung J; Munzner J; Sobol Z; Sluggett G; Zelesky T; Sutter A; Wichard J
Regul Toxicol Pharmacol; 2015 Jul; 72(2):335-49. PubMed ID: 25980641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
